The assessment of halitosis with a new screening tool in medication-related osteonecrosis of the jaw
ConclusionsQuantifying the level of halitosis can be used to screen for MRONJ in patients taking bisphosphonates, such as patients with osteoporosis, prostate cancer, and breast cancer.Clinical RelevanceMRONJ is accompanied by bad breath, and the concentrations of hydrogen sulfide and methyl mercaptan are associated with MRONJ.
Source: Clinical Oral Investigations - Category: Dentistry Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Dentistry | Oral Cancer | Orthopaedics | Osteoporosis | Prostate Cancer | Study